On May 16, 2022 Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, reported that members of the Company’s management team will participate at the following investor conferences in May 2022 (Press release, Altimmune, MAY 16, 2022, View Source [SID1234614664]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright Global Investment Conference
Tuesday, May 24, 2022
7:00 am Eastern Time
The session will be webcast and can be accessed by visiting the Events section of the Altimmune website.
B. Riley Securities Institutional Investor Conference
Thursday, May 26, 2022
1:00 pm Pacific Time
The session will be an in person fireside chat.